Literature DB >> 27115024

Data describing the effect of DRD4 promoter polymorphisms on promoter activity.

Shoin Tei1, Hiroaki Mitsuhashi1, Shoichi Ishiura1.   

Abstract

This data article tested whether polymorphisms within the dopamine D4 receptor (DRD4) gene promoter can lead to differences in the promoter activity. The variants, a 120-bp variable number tandem repeat (VNTR), -906 T/C, -809 G/A, -616G/C, and -521C/T, were introduced into the DRD4 promoter and the promoter activity was measured in a neural cell line using the luciferase assay. However, no differences were detected among the haplotypes investigated, and the in vitro data obtained from our protocol could not support the involvement of DRD4 promoter polymorphisms in heritable human traits.

Entities:  

Year:  2016        PMID: 27115024      PMCID: PMC4833125          DOI: 10.1016/j.dib.2016.03.084

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specification Table

Value of the data

We examined the effect of DRD4 promoter polymorphisms on gene expression in an in vitro reporter gene experiment. This data is useful for characterising the link between heritable mental traits and the polymorphisms. Our data can provide insight into methodology and considerations for investigation of polymorphisms in non-coding regions.

Data

Endogenous dopamine D4 receptor (DRD4) gene expression in SH-SY5Y cells was detected by RT-PCR using cDNA derived from the cell line (Fig. 1).
Fig. 1

RT-PCR analysis of DRD4 gene expression. DRD4 expression in SH-SY5Y cells was detected using RT-PCR. The housekeeping gene GAPDH was amplified as an internal control.

To test whether the polymorphisms within the promoter change the promoter activity, luciferase activity was measured under the influence of the DRD4 promoter into which polymorphisms were introduced (Fig. 2 and Table 1). All of the reporter plasmids containing the DRD4 fragment exhibited significantly higher luciferase activity than the control pGL3-Basic, and although every possible combination of haplotypes was investigated, there were no activity differences among the introduced mutations in SH-SY5Y cells (Fig. 3, Fig. 4).
Fig. 2

Schematic representation of the DRD4 gene and the reporter construct with the locations of the polymorphisms studied. The DNA fragment cloned here corresponded to region −1576 to −1 relative to the translation start site, and was the longest among functional assays on mutated DRD4 promoter;−591 to −123 was cloned in Okuyama et al [2], −1389 to −1203 in D׳Souza et al. [3], −668 to −389 in Kreszturi et al. [4] and −1571 to −389 in Kreszturi et al. [5].The putative silencer (dark grey boxes, −1571 to −800 and −770 to −678) and enhancer (light grey box, −591 to −123) regions are indicated in the DRD4 gene promoter (white arrow) [1], [4]. The 120-bp VNTR is 1.2 kb upstream from the initial codon, and −521C/T is a C/T SNP at −521 in the promoter region (the description can be applied to the other SNPs). The promoter was cloned upstream of the firefly luciferase gene, so that luciferase expression was driven by the promoter. pGL3 promoter which contains SV40 promoter upstream luciferase gene was used as positive control.

Table 1

The constructed haplotypes consisted of 120-bp VNTR and four SNPs of the DRD4 gene.

Reporter construct120 bp VNTR−906 C/T−809 G/A−616 G/C−521 C/T
1R-WT1TGGC
1R-5211TGGT
1R-6161TGCC
1R-8091TAGC
1R-9061CGGC
2R-WT2TGGC
2R-5212TGGT
2R-6162TGCC
2R-8092TAGC
2R-9062CGGC
1R-521-6161TGCT
1R-521-8091TAGT
1R-521-9061CGGT
1R-616-8091TACC
1R-616-9061CGCC
1R-809-9061CAGC
1R-521-616-8091TACT
1R-521-616-9061CGCT
1R-521-809-9061CAGT
1R-616-809-9061CACC
1R-521-616-809-9061CACT
2R-521-6162TGCT
2R-521-8092TAGT
2R-521-9062CGGT
2R-616-8092TACC
2R-616-9062CGCC
2R-809-9062CAGC
2R-521-616-8092TACT
2R-521-616-9062CGCT
2R-521-809-9062CAGT
2R-616-809-9062CACC
2R-521-616-809-9062CACT
Fig. 3

The effect of the polymorphisms on the DRD4 promoter activity. DRD4 promoter activity was measured as the luciferase activity in SH-SY5Y cells. The relative luciferase activity of pGL3-Basic was defined as 1 and pGL3 promoter was used as positive control. The assay failed to detect any significant differences between haplotypes. Data are expressed as means±SD (n=5) (Tukey–Kramer test, **p<0.01).

Fig. 4

The effect of the combined polymorphisms on the DRD4 promoter activity. DRD4 promoter activity was measured as luciferase activity in SH-SY5Y cells. The relative luciferase activity of pGL3-Basic was defined as 1 and pGL3 promoter was used as positive control. The assay failed to detect any significant differences between haplotypes. Data are expressed as means±SD (n=4) (Tukey–Kramer test, **p<0.01).

Experimental design, materials and methods

Construction of reporter plasmid

A DNA fragment spanning −1576 to −1 of the DRD4 promoter region was amplified from human genomic DNA with TaKaRa LA Taq (TaKaRa) and inserted into pCR-Blunt (Life Technology). The cloned sequence was confirmed by Sanger sequencing and shown in Supplementary Fig. 1. Mutations were introduced using PCR-based site-directed mutagenesis for the four SNPs, and with NotI treatment for the VNTR; DNA ligation after NotI treatment converts a 2-repeat allele into a 1-repeat allele because one NotI recognition site is present within the repeat. The mutated insertion was subcloned into the XhoI and HindIII sites of pGL3-Promoter Vector (Promega) replacing the original SV40 promoter with the DRD4 promoter. The primer sequences used for construction are shown in Table 2.
Table 2

Primer sequences and application.

ApplicationForwardReverse
Amplification of DRD4 promoterACCActcgaGAGGCTGGGCTGGACTCGCCGTTTAAGGaagcttGGCGCGCCCGGGCGG
The lower-case letters represent XhoI or HindIII restriction sites.
Nucleotide substitution −916 T>CGAAGAGTCCATAGAACTCTCTGCTGCGCTTTGCGCAAAGCGCAGCAGAGAGTTCTATGGACTCTTC
Nucleotide substitution −809 G>ACGAGCCGAACCTACTGTCCGGTCCCGCGGGACCGGACAGTAGGTTCGGCTCG
Nucleotide substitution −616 G>CGCGGGGGCTGAGCACCAGAGGCTGCGCAGCCTCTGGTGCTCAGCCCCCGC
Nucleotide substitution −521 T>CGCGTGGAGGGCGCGCACGAGGCCTCGTGCGCGCCCTCCACGC
The underlined letters correspond to each SNP
RT-PCR of DRD4GCACCGCCTCCATCTTCAACCCGGAACGTGGCCCAGTAGAGC
RT-PCR of GAPDHAAGGCTGAGAACGGGAAGCTTGTCATCAATTTCCCGTCTAGCTCAGGGATGACCTTGCCC

Cell culture and transfection

Human neuroblastoma SH-SY5Y cells were cultured in Dulbecco׳s Modified Eagle׳s Medium (Sigma-Aldrich) supplemented with 10% foetal bovine serum (Invitrogen) at 37 °C in a humidified atmosphere containing 5% CO2. Twenty-four hours before transfection, cells were plated at 4×105 cells/well in 96-well plates. The reporter plasmid (0.2 ng/well) and pRL-TK (0.01 ng/well) were transfected into SH-SY5Y cells with 0.06 μL/well FuGENE 6 Transfection Reagent (Promega), according to the manufacturer׳s protocol.

Luciferase assay

Forty-eight hours after transfection, the luciferase activity was measured in quadruplicate with the Dual-Glo Luciferase assay System (Promega) using Centro LB960 (Berthold), following the manufacturer׳s instructions. Relative luciferase activity was calculated as the ratio of firefly to Renilla luciferase activity.

Total RNA isolation and RT-PCR

Total RNA of SH-SY5Y was extracted with GenElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich). First-strand cDNA was synthesised from extracted RNA using Prime Script RT Reagent Kit with gDNA Eraser (Perfect Real Time) (TaKaRa). DRD4 mRNA expression was detected using TaKaRa LA Taq, as described [1]. To verify the procedure, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified as an internal control. The primer sequences used for RT-PCR are shown in Table 2.
Subject areaBiology
More specific subject areaMolecular biology, Genetics
Type of dataTable, image, graph
How data was acquiredRT-PCR, Luciferase assay
Data formatRaw, analysed
Experimental factorsPolymorphisms (120-bp VNTR, rs3758653 for −906 T/C, rs936461 for −809 G/A, rs747302 for −616 G/C, and rs1800955 for −521 C/T) were introduced into the promoter sequence of the DRD4 gene
Experimental featuresDRD4 expression was detected by RT-PCR using cDNA from SH-SY5Y cells. Firefly luciferase gene downstream of DRD4 promoter was expressed in SH-SY5Y cells, and the luciferase activity of each construct was measured 48 h after transfection
Data source locationUniversity of Tokyo, Japan
Data accessibilityData supplied with this article
  5 in total

1.  Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses.

Authors:  Eva Kereszturi; Orsolya Kiraly; Zsolt Csapo; Zsanett Tarnok; Julia Gadoros; Maria Sasvari-Szekely; Zsofia Nemoda
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

2.  Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene.

Authors:  S Kamakura; A Iwaki; M Matsumoto; Y Fukumaki
Journal:  Biochem Biophys Res Commun       Date:  1997-06-18       Impact factor: 3.575

3.  Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait.

Authors:  Y Okuyama; H Ishiguro; M Nankai; H Shibuya; A Watanabe; T Arinami
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

4.  Functional effects of a tandem duplication polymorphism in the 5'flanking region of the DRD4 gene.

Authors:  Ursula M D'Souza; Carsten Russ; Eda Tahir; Jonathan Mill; Peter McGuffin; Philip J Asherson; Ian W Craig
Journal:  Biol Psychiatry       Date:  2004-11-01       Impact factor: 13.382

5.  No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity.

Authors:  Eva Kereszturi; Orsolya Kiraly; Csaba Barta; Noemi Molnar; Maria Sasvari-Szekely; Zsolt Csapo
Journal:  BMC Mol Biol       Date:  2006-05-24       Impact factor: 2.946

  5 in total
  1 in total

1.  Genetic Variants Associated With Resilience in Human and Animal Studies.

Authors:  Stephanie Cahill; Tarani Chandola; Reinmar Hager
Journal:  Front Psychiatry       Date:  2022-05-20       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.